Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hypertension Diagnostics Inc. stock logo
HDII
Hypertension Diagnostics
$0.00
$0.00
$0.00
N/A-0.07N/AN/A
Presbia PLC stock logo
LENSF
Presbia
$0.02
$0.02
$0.00
$0.19
$257K5.915,650 shsN/A
VRSEF
Verisante Technology
$0.00
$0.00
$0.00
$0.01
$100K18.349 shsN/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hypertension Diagnostics Inc. stock logo
HDII
Hypertension Diagnostics
0.00%0.00%0.00%0.00%-50.00%
Presbia PLC stock logo
LENSF
Presbia
0.00%0.00%0.00%0.00%0.00%
VRSEF
Verisante Technology
0.00%0.00%+4.76%-56.00%-4.35%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Hypertension Diagnostics Inc. stock logo
HDII
Hypertension Diagnostics
N/AN/AN/AN/AN/AN/AN/AN/A
Presbia PLC stock logo
LENSF
Presbia
N/AN/AN/AN/AN/AN/AN/AN/A
VRSEF
Verisante Technology
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Hypertension Diagnostics Inc. stock logo
HDII
Hypertension Diagnostics
0.00
N/AN/AN/A
Presbia PLC stock logo
LENSF
Presbia
0.00
N/AN/AN/A
VRSEF
Verisante Technology
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Hypertension Diagnostics Inc. stock logo
HDII
Hypertension Diagnostics
N/AN/AN/AN/AN/AN/A
Presbia PLC stock logo
LENSF
Presbia
N/AN/AN/AN/AN/AN/A
VRSEF
Verisante Technology
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Hypertension Diagnostics Inc. stock logo
HDII
Hypertension Diagnostics
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Presbia PLC stock logo
LENSF
Presbia
N/AN/A0.00N/AN/AN/AN/AN/A
VRSEF
Verisante Technology
-$80KN/A0.00N/AN/AN/A-901.36%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Hypertension Diagnostics Inc. stock logo
HDII
Hypertension Diagnostics
N/AN/AN/AN/AN/A
Presbia PLC stock logo
LENSF
Presbia
N/AN/AN/AN/AN/A
VRSEF
Verisante Technology
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Hypertension Diagnostics Inc. stock logo
HDII
Hypertension Diagnostics
N/AN/AN/A
Presbia PLC stock logo
LENSF
Presbia
N/AN/AN/A
VRSEF
Verisante Technology
N/A
0.53
0.53

Institutional Ownership

CompanyInstitutional Ownership
Hypertension Diagnostics Inc. stock logo
HDII
Hypertension Diagnostics
N/A
Presbia PLC stock logo
LENSF
Presbia
N/A
VRSEF
Verisante Technology
N/A

Insider Ownership

CompanyInsider Ownership
Hypertension Diagnostics Inc. stock logo
HDII
Hypertension Diagnostics
40.00%
Presbia PLC stock logo
LENSF
Presbia
74.20%
VRSEF
Verisante Technology
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Hypertension Diagnostics Inc. stock logo
HDII
Hypertension Diagnostics
2,017N/AN/ANot Optionable
Presbia PLC stock logo
LENSF
Presbia
2017.12 millionN/ANot Optionable
VRSEF
Verisante Technology
N/A43.94 millionN/ANot Optionable

Recent News About These Companies

VER.H:CA Analysis
Verisante Technology, Inc. Announces RTO Update:
Verisante: Q4 Earnings Snapshot
Verisante Technology, Inc. Announces 2023 AGM Results
Verisante: Q2 Earnings Snapshot
Latest Technology News
Verisante: Q3 Earnings Snapshot
Hypertension Diagnostics stock logo

Hypertension Diagnostics OTCMKTS:HDII

Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marker of cardiovascular disease. The company offers CVProfilor DO-2020, which provides a patient's arterial elasticity indices used in the assessment for underlying vascular disease; CVProfilor MD-3000 that offers a sensitive and specific guide to the presence of blood vessel disease; and HD/PulseWave CR-2000 research cardiovascular profiling system, which provides researchers and scientists with a non-invasive means to assess arterial elasticity in support of human research in various areas. Its products collect 30 seconds of blood pressure waveform data, perform an analysis of the digitized blood pressure waveforms, and generate a CVProfile report that contains information on blood pressure, heart rate, pulse pressure, body surface area, body mass index, and C1-large and C2-small artery elasticity indices. The company sells its products to primary care physicians, cardiologists, health care professionals, trained medical personnel, research investigators at academic medical research centers, government institutes, cardiovascular specialists, and pharmaceutical firms. It markets its products through a representative organization in the United States. Hypertension Diagnostics, Inc. was founded in 1988 and is based in Richmond Hill, Canada.

Presbia stock logo

Presbia OTCMKTS:LENSF

$0.02 0.00 (0.00%)
As of 10/21/2022

Presbia PLC, an ophthalmic device company, develops and markets optical lens implants for treating presbyopia. The company provides the refractive lens for patient surgeries, as well as accessories for procedures. It primarily operates in the United States, South Korea, Australia, Italy, the Netherlands, Ireland, Canada, and Germany. The company was founded in 2014 and is headquartered in Dublin, Ireland.

Verisante Technology OTCMKTS:VRSEF

$0.0022 0.00 (0.00%)
As of 06/20/2025

Verisante Technology Inc. does not have significant operations. Previously, it was involved in the design and manufacture of cancer diagnostic devices. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology Inc. in January 2011. The company was incorporated in 2006 and is based in Vancouver, Canada.